Kristina Chen Email & Phone Number

New York, New York, Us

HTA Value & Evidence Lead, breast cancer and early development programs.

New York, New York, Us

New York, New York, Us

Global health economics and outcomes research, rare diseases and early pipeline

San Diego, Ca, Us

Product lead, development in value access strategy, patient- reported outcomes (PRO), real world evidence, decision and economic modeling

Tokyo, Jp

Tokyo, Jp, Jp

Lead multiple products with rare diseases indications. Provide global strategy input for development of product value propositions. Strategically device evidence generation plan for each products based on product’s stage in life cycle, clinical benefits and comparative edge of the products. Execute evidence generation plans with rigorous scientific research process and analytical methods to support product values and gain market access for the products globally. Work with Global Market Access to generate evidence to support submissions to various health technology assessment (HTA) agencies outside of US. • Lead and contribute to global product strategies and align with the goals among members of the Global Development Team (GDT) (clinical and medical teams) and Global Value Team (GVT) (commercial, market access, clinical, etc.) for rare disease business unit • Support development and implementation of GHEORE studies in the product strategy agreed upon by GVT to demonstrate the values of Shire’s products to key stakeholders (patients, clinicians and payers)• Provide support on current research methods, tools and data sources to ensure study designs and data interpretations are technically accurate and appropriate for market access, commercialization and publication needs• Engaging cross functional team members of the products and effectively executing strategy via internal teams and external consultants• Execute product evidence generation plans and managing all research projects to meet GHEORE product goals set with cross functional teams• Effectively communicate strategy input, GHEORE product goals, study designs and analytical plans, and results to cross functional teams • Disseminate study results internally at key cross functional team meetings (product strategy team and GDT) and externally at key clinical congresses and manuscript publications

Provided consultation to clients for their business needs in market access• Developed proposals and study protocols for evidence generation to understand areas of unmet needs in current treatment for type 1 and type 2 diabetes mellitus using real world data• Devised study analytical plans for retrospective data analyses using electronic medical record databases from global settings (e.g. US, Germany) to generate evidence to support client’s needs in global market access

Thousand Oaks, Ca, Us

Worked on an oncology supportive product and a pipeline product in neuroscience. Collaborated with Global Health Economics product teams to devise product portfolio investment plan and communicate plan to cross-functional teams including clinical, commercial, market value access and payers functions. Assisted alignment of goals for supporting product value propositions across functions. • Updated and developed value propositions for a cancer supportive product.• Interacted with Medical Communications to provide product value messages and supporting data for preparation of materials to support regional field staff.• Communicated with Medical Writing to update existing dossier and align dossier content with value messages. • Developed and managed research projects to provide clinical and economics evidence to support medical, commercial and market value access goals.• Collaborated with Clinical Development team to identify PRO trial endpoints and devise analytical plans in phase II for small-cell lung cancer • Developed a disease specific patient reported outcomes instrument in accordance with FDA guidelines to support labeling claim.• Managed in content development phase of a patient-reported-outcome instrument development for a pipeline product.

Boston, Ma, Us

Developed proposals, estimated project budgets, devised analysis plans and provided case management for multiple case types including large claims data analyses, health economics models, pharmacovigilance using MedWatch™ and Vigibase™ databases, prospective patient surveys, and medical chart reviews. • Managed projects, delegated project tasks, managed project budgets and timelines, and analyzed data. Communicated, analysis plans and project results to clients. • Developed Markov cost-effectiveness models, budget impact models, and early phase pricing models for oncology products for treatment of multiple myeloma and lung cancer• Devised analysis plans for a patient chart review study and analyzed data for products in renal carcinoma • Coordinated and collaborated with both internal and external case members and external vendors to develop electronic case reporting form for chart review. • Collaborated with numerous clinics for participation in chart review studies and presented projects at various professional and clinical conferences. • Developed and submitted manuscripts for publication in peer-reviewed journals.

Developed health economic models and budget impact models using MS Excel®. Devised strategic planning in research and analysis plans for clients’ products throughout various development stages and post-marketing. • Provided consultation on the economic endpoints for Phase II and III clinical trials. • Developed product dossiers to help clients communicate their product values to health care decision makers. • Presented projects at various conferences.

Master Of Science (M.S.), Pharmaceutical Economics And Policy

Doctor Of Pharmacy (Pharm.D.), Pharmacy

Bachelor Of Science - Bs, Biology/Biological Sciences, General